Cargando…
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
OBJECTIVES: We aimed to determine the interobserver reproducibility of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) criteria for magnetic resonance imaging in patients on active surveillance (AS) for prostate cancer (PCa) at two different academic centres....
Autores principales: | Giganti, Francesco, Pecoraro, Martina, Stavrinides, Vasilis, Stabile, Armando, Cipollari, Stefano, Sciarra, Alessandro, Kirkham, Alex, Allen, Clare, Punwani, Shonit, Emberton, Mark, Catalano, Carlo, Moore, Caroline M., Panebianco, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062656/ https://www.ncbi.nlm.nih.gov/pubmed/31844959 http://dx.doi.org/10.1007/s00330-019-06557-2 |
Ejemplares similares
-
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020) -
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021) -
Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?
por: Messina, Emanuele, et al.
Publicado: (2023) -
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017) -
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022)